TETRA Technologies(TTI)
Search documents
The Radoff-Torok Group Nominates Four Highly Qualified, Independent Director Candidates for Election to the TETRA Technologies Board of Directors
Prnewswire· 2025-03-24 14:37
Core Viewpoint - The Radoff-Torok Group, owning over 4.9% of TETRA Technologies, Inc. (TTI), is advocating for significant changes to the Board of Directors due to long-term underperformance, lack of strategy, and poor governance, believing that new independent directors are essential for creating long-term value for stockholders [1][2][5]. Group 1: Board Performance and Governance - The current TTI Board is perceived as more focused on preserving the positions of its long-tenured members rather than addressing corporate strategy and governance failures [1][4]. - The Radoff-Torok Group has attempted to engage constructively with the Board over the past five months but has faced rejection of their proposals for board refreshment and improved governance [3][4]. - The Board's refusal to acknowledge its underperformance, evidenced by a nearly 43% decline in TTI's stock price over the last decade compared to a 66% return for the Russell 2000, highlights a disconnect with stockholder interests [6][10]. Group 2: Proposed Changes and Nominees - The Radoff-Torok Group has nominated four independent director candidates—Simon Bates, Evan Behrens, Bradley L. Radoff, and Andrew K. Ruben—believing their expertise will help transition TTI into a more focused and profitable business [5][11]. - The nominees collectively possess extensive experience in relevant industries and public company governance, which the Radoff-Torok Group believes is necessary for effective oversight and strategic direction [11][12]. Group 3: Strategic Recommendations - The Radoff-Torok Group recommends the formation of a Strategy Committee of independent directors to review TTI's business portfolio and capital structure, aiming to unlock value and reduce corporate overhead [7][8]. - Addressing succession planning and capital allocation flaws is deemed critical for restoring TTI's credibility in the market, especially given the current leadership's inability to create stockholder value [8][10].
TETRA TECHNOLOGIES, INC. HIRES KURT HALLEAD AS TREASURER AND VICE PRESIDENT OF INVESTOR RELATIONS
Prnewswire· 2025-03-10 21:00
Core Viewpoint - TETRA Technologies, Inc. has appointed Kurt Hallead as Treasurer and Vice President of Investor Relations, bringing extensive experience in the energy sector [1][2]. Company Overview - TETRA Technologies, Inc. is an energy services and solutions company focused on environmentally conscious services and solutions, operating on six continents [3]. - The company's portfolio includes Energy Services, Industrial Chemicals, and Critical Minerals, with a commitment to expanding into the low-carbon energy market [3]. - TETRA provides products and services to the oil and gas industry and calcium chloride for various applications, aiming to meet the demand for sustainable energy in the 21st century [3].
TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN THE ROTH 37TH ANNUAL CONFERENCE
Prnewswire· 2025-03-10 13:35
Company Overview - TETRA Technologies, Inc. is an energy services and solutions company focused on environmentally conscious services and solutions [2] - The company operates on six continents and has a portfolio that includes Energy Services, Industrial Chemicals, and Critical Minerals [2] - TETRA provides products and services to the oil and gas industry and calcium chloride for diverse applications [2] - The company is expanding into the low-carbon energy market, leveraging chemistry expertise, key mineral acreage, and global infrastructure to meet sustainable energy demands [2] Conference Participation - TETRA's senior management will participate in the Roth 37th Annual Conference in Dana Point, California on March 17 and 18, 2025 [1] - CEO Brady Murphy and VP of Investor Relations Kurt Hallead will host one-on-one meetings with institutional investors during the conference [1]
TETRA Technologies(TTI) - 2024 Q4 - Earnings Call Transcript
2025-02-26 18:43
Financial Data and Key Metrics Changes - The fourth quarter adjusted EBITDA margins improved to 17% from 16.6% in the third quarter and 15.8% in the fourth quarter of 2023, despite lower revenue quarter on quarter and year on year [8] - The company achieved a record volume of 89 million barrels of treated and recycled produced water for frac reuse in the fourth quarter [10] - For the first half of 2025, the company projects net income before taxes between $19 million and $34 million and adjusted EBITDA between $55 million and $65 million, approaching or exceeding a ten-year record high [21][22] Business Line Data and Key Metrics Changes - The Water and Flowback segment achieved EBITDA margins of 13.8%, impacted by a year-end completion slowdown, with rig count and frac fleet count down more than double digits from last year [10] - The Completion Fluids and Products segment revenue was down 1% for the full year but grew EBITDA by 2% year over year, with total revenue of $311 million, the second highest since 2015 [11] - The industrial chemicals business achieved its highest revenue and adjusted EBITDA in the company's history, with 2024 revenue growth over 2023 of over 9% [12] Market Data and Key Metrics Changes - The company noted a decline in rig count and frac fleets by 17% and 30%, respectively, over the past two years, while the volume of produced water continues to increase [16] - The company expects to ramp up meaningful volumes of zinc bromide-based electrolyte, which is anticipated to increase its contribution to total revenue [12] Company Strategy and Development Direction - The company is focusing on solutions for produced water treatment and recycling, including desalination for beneficial reuse, as part of its capital allocation strategy [10][14] - Strategic investments in Brazil and the Gulf of America are expected to support increased deepwater activity and contribute to strong free cash flow in the first half of 2025 [14][34] - The company is exploring capital-light solutions for bromine production and lithium opportunities, aiming to fund projects through free cash flow without taking on debt [24][26][37] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the performance of the U.S. business, driven by strong activity in the Gulf of Mexico and the growing long-duration battery electrolyte business [30] - The company anticipates a strong start to 2025, projecting significant year-over-year increases in both revenue and EBITDA in the first half of 2025 [21][22] - Management highlighted the importance of addressing the industry's challenge of produced water disposal and the potential for regulatory restrictions [18][19] Other Important Information - The company eliminated the valuation allowance for deferred taxes, reflecting confidence in utilizing net operating loss carryforwards in the coming years [30] - Cash on hand at the end of December was $37 million, with total liquidity of almost $207 million as of the conference call date [38] Q&A Session Summary Question: Insights on 2025 growth opportunities - Management indicated that the first half of 2025 will benefit from longer-term projects, with a focus on the CS Neptune pipeline and increased electrolyte volumes from Eos [49][50] Question: Guidance for second half of 2025 - Management expressed caution regarding visibility for the second half of 2025 but noted confidence in ongoing deepwater projects and electrolyte sales [58] Question: Capacity for pilot projects in desalination - Management confirmed the ability to place orders for additional pilot units in 2025, with ongoing discussions for several pilots [66] Question: Revenue contribution from Brazil deepwater program - Management stated that the Brazil deepwater program is expected to contribute significantly over the next two years, with a focus on heavier brine completion projects [68] Question: Bromine project timeline - Management indicated that the lead time for the bromine project is longer than a few months, with significant progress already made in engineering and site preparation [72] Question: Demand for recycled water and customer discussions - Management noted increasing momentum for the Oasis solution, with ongoing discussions with operators and the need to address regulatory and logistical challenges [80][82]
TETRA Technologies(TTI) - 2024 Q4 - Earnings Call Transcript
2025-02-26 16:32
Financial Data and Key Metrics Changes - The fourth quarter adjusted EBITDA margins improved to 17% from 16.6% in the third quarter and 15.8% in the fourth quarter of 2023, despite lower revenue quarter on quarter and year on year [6][5] - For the full year, the Completion Fluids and Products segment revenue was down 1%, but EBITDA grew by 2% year over year, with total revenue of $311 million, the second highest since 2015 [7][8] - The Industrial Chemicals business achieved record revenue and adjusted EBITDA for the fourth quarter, with a revenue growth of over 9% in 2024 compared to 2023, representing 22% of TETRA's total revenue [8][9] Business Line Data and Key Metrics Changes - The Water and Flowback segment achieved EBITDA margins of 13.8%, impacted by a year-end completion slowdown, with rig count and frac fleet count down more than double digits from last year [6][10] - The Industrial Chemicals segment is expected to ramp up meaningful volumes of zinc bromide-based electrolyte, contributing to future revenue growth [8][9] - The Water and Flowback Services segment is expected to maintain flat revenue in 2025 while increasing margins through operational efficiencies [11] Market Data and Key Metrics Changes - The company achieved a record volume of 89 million barrels of treated and recycled produced water for frac reuse in the fourth quarter [7] - The company is focusing on expanding its market presence in Northern Europe and the U.S., which provides stable markets with predictable revenue and earnings [9] Company Strategy and Development Direction - The company is making strategic investments in Brazil to support a large Deepwater Completion Fluids Award starting in Q2 2025, and is also increasing deepwater activity in the Gulf of America [9][10] - The company is prioritizing desalination solutions for produced water treatment and recycling, aiming to position itself as an industry leader in this area [11][12] - The company is exploring capital-efficient alternatives for its bromine project and lithium opportunities, focusing on cash flow generation and minimizing debt [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the U.S. business performance, driven by strong activity in the Gulf of America and the calcium chloride business [21] - The company projects net income before taxes between $19 million and $34 million and adjusted EBITDA between $55 million and $65 million for the first half of 2025, indicating a strong start to the year [14][24] - Management highlighted the importance of automation and desalination in improving margins and cash flow generation in the Water and Flowback segment [11][13] Other Important Information - The company eliminated the valuation allowance for deferred taxes, reflecting confidence in utilizing net operating loss carryforwards, potentially saving approximately $97.5 million in cash taxes [20][21] - The company reported cash on hand of $37 million and total liquidity of nearly $27 million as of December [26] Q&A Session Summary Question: Insights on growth opportunities for 2025 - Management indicated that the first half of 2025 will benefit from long-term projects, with expectations for increased volumes from Eos Energy and pilot operations in desalination [32][33] Question: Variances in EBITDA projections for the second half of 2025 - Management noted that while visibility is limited for the second half, they expect continued performance improvement driven by deepwater projects and electrolyte sales [38] Question: Capacity for pilot projects in desalination - Management confirmed high confidence in multiple pilot projects for 2025, with ongoing discussions and potential orders for additional pilot units [43][61] Question: Revenue recognition timeline for shipments to Eos - Revenue is recognized when the product leaves the facility, with a short timeframe for the product to be used in batteries [78] Question: Future structure of the company - Management anticipates a continued focus on industrial chemicals and deepwater services, with potential evolution of the water and flowback business towards desalination [75][76]
Tetra Technologies (TTI) Q4 Earnings and Revenues Miss Estimates
ZACKS· 2025-02-26 00:20
Tetra Technologies (TTI) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -25%. A quarter ago, it was expected that this oil and gas services company would post earnings of $0.03 per share when it actually produced earnings of $0.03, delivering no surprise.Over the last four quarters, ...
TETRA Technologies(TTI) - 2024 Q4 - Annual Report
2025-02-25 22:11
Financial Performance - Consolidated revenues for 2024 decreased by $27.151 million, or 4.3%, to $599.111 million compared to $626.262 million in 2023[206] - Gross profit decreased by $13.792 million, or 9.0%, resulting in a gross profit margin of 23.3% for 2024, down from 24.5% in 2023[206] - Income before discontinued operations increased significantly by $88.141 million, or 345.9%, to $113.620 million in 2024 compared to $25.479 million in 2023[206] - Net income attributable to TETRA stockholders rose by $82.500 million, or 320.0%, reaching $108.284 million in 2024, up from $25.784 million in 2023[206] - Adjusted EBITDA for 2024 was $99.4 million, representing 16.6% of total revenue, compared to $106.8 million and 17.1% in 2023, indicating a slight decline in profitability[227] - Total revenue for 2024 was $599.1 million, a decrease from $626.3 million in 2023, reflecting a challenging market environment[227] Division Performance - The Completion Fluids & Products Division reported revenues of $311.301 million, a slight decrease of $1.729 million, or 0.6%, from $313.030 million in 2023[214] - The Water & Flowback Services Division experienced a revenue decline of $25.422 million, or 8.1%, with total revenues of $287.810 million in 2024 compared to $313.232 million in 2023[217] Expenses and Costs - General and administrative expenses decreased by $6.621 million, or 6.9%, to $89.969 million in 2024 from $96.590 million in 2023[206] - Corporate overhead loss before taxes decreased by $7.5 million, or 10.3%, from $72.3 million in 2023 to $64.9 million in 2024, primarily due to an $8.3 million increase in unrealized gains on investments[222] - Operating cash flows decreased by $33.7 million, from $70.2 million in 2023 to $36.5 million in 2024, primarily due to decreased activity levels and changes in product mix[230] - General and administrative expenses decreased by $4.0 million, or 8.2%, primarily due to a $4.5 million reduction in salary-related expenses[222] Tax and Valuation - The effective tax rate for 2024 was (295.3)%, a significant change from 19.6% in 2023, primarily due to the reversal of the valuation allowance related to deferred tax assets[213] Strategic Investments and Projects - The company is focusing on strategic investments in TETRA CS Neptune fluids and water desalination projects to enhance near-term results[203] - A definitive feasibility study for bromine production was published in August 2024, with ongoing negotiations for bridging supply agreements to support future operations[202] - The company is negotiating bridging supply agreements for bromine, which may allow for flexibility in plant start-up timing and defer investments in Arkansas[232] Capital Expenditures and Liquidity - Total cash capital expenditures in 2024 were $60.7 million, with $23.4 million allocated to the Water & Flowback Services Division and $37.0 million to the Completion Fluids & Products Division[231] - Liquidity at the end of Q4 2024 was $182.2 million, consisting of $37.0 million in unrestricted cash and $145.2 million in available credit[228] - The company entered into a $265.0 million Term Credit Agreement in January 2024 to refinance prior debt and support the Arkansas bromine processing project[236] - A $5.5 million loss on debt extinguishment was recorded in 2024 due to non-cash unamortized finance costs related to the repayment of the previous Term Credit Agreement[222] Debt and Credit Facilities - The amended ABL Credit Agreement provides a senior secured revolving credit facility of up to $100.0 million with a $25.0 million accordion, maturing on May 13, 2029[238] - As of December 31, 2024, the company had no balance outstanding under the ABL Credit Agreement and $65.7 million available, increasing to $79.8 million as of February 25, 2025[239] - The Swedish Credit Facility has an availability of approximately $4.5 million as of December 31, 2024, with an interest rate of 2.95% per annum, expiring on December 31, 2025[240] - The Finland Credit Agreement had $1.4 million of letters of credit outstanding as of December 31, 2024, and has been renewed through January 31, 2026[241] - The New Term Credit Agreement consists of a $190.0 million funded term loan and a $75.0 million delayed-draw term loan, with a weighted average interest rate of 10.23%[256][257] Asset Management - The company sold its Kodiak shares for proceeds of $19.0 million in January 2025, net of transaction and broker fees[243] - As of December 31, 2024, the market value of equity holdings in Kodiak and Standard Lithium were $18.4 million and $1.2 million, respectively[243] - The company may consider divesting non-core assets and engaging in strategic transactions to enhance its business[244] Compliance and Risk - The company is in compliance with all covenants of its debt agreements as of December 31, 2024[242] - The company has currency exchange rate risk exposure related to revenues and expenses in foreign currencies, with no foreign currency exchange contracts outstanding as of December 31, 2024[258]
TETRA Technologies(TTI) - 2024 Q4 - Annual Results
2025-02-25 22:03
Exhibit 99.1 TETRA TECHNOLOGIES, INC. ANNOUNCES FOURTH QUARTER AND TOTAL YEAR 2024 RESULTS AND PROVIDES FIRST-HALF 2025 GUIDANCE Fourth Quarter Financial Highlights THE WOODLANDS, Texas, February 25, 2025 / PR Newswire / - TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) today announced fourth quarter and total year 2024 results. Brady Murphy, TETRA's President and Chief Executive Officer, stated, "Our fourth quarter results were in-line with our expectations as strong offshore activity led by ...
TETRA TECHNOLOGIES, INC. ANNOUNCES FOURTH QUARTER AND TOTAL YEAR 2024 RESULTS AND PROVIDES FIRST-HALF 2025 GUIDANCE
Prnewswire· 2025-02-25 22:00
Core Insights - TETRA Technologies, Inc. reported fourth quarter and total year 2024 results, highlighting a mixed performance with strong offshore activity but weaker U.S. onshore activity [1][2] - The company achieved an adjusted EBITDA margin of 17.0%, an improvement from previous quarters, despite a decrease in revenue [2][5] - TETRA's strategic focus on produced water led to record high treatment and recycling volumes, alongside the successful commercial launch of the TETRA Oasis Total Desalination Solution [2][8] Financial Performance - Fourth quarter 2024 revenue was $135 million, a decrease of 5% from the third quarter [5][16] - Net income from continuing operations was $102 million, significantly higher than $2.8 million in the previous quarter, largely due to non-recurring tax credits [5][10] - Adjusted EBITDA for the fourth quarter was $22.8 million, down 3% from the third quarter, with margins impacted by lower production volumes [6][9] Cash Flow and Investments - Cash flow from operating activities was $5.6 million, a decline from $19.9 million in the third quarter [7][10] - The company reported an adjusted free cash flow use of $9.3 million in the fourth quarter, compared to a positive $6.3 million in the third quarter [7][10] - TETRA monetized its equity investment in Kodiak Gas Services, generating approximately $19 million in cash proceeds [2][6] Strategic Initiatives - TETRA invested $22 million in strategic initiatives in Arkansas, focusing on engineering and reservoir studies for a bromine project [10][11] - The company anticipates a strong first half of 2025, with expected net income before taxes between $19 million and $34 million [3][12] - TETRA is prioritizing projects that can impact near-term results, including TETRA CS Neptune fluids and water desalination technologies [12][11] Tax and Deferred Assets - A favorable adjustment of $97.5 million to deferred tax assets was recognized, reflecting TETRA's profitable position and expectations of stronger future profits [4][15] - The company estimates that its U.S. federal tax loss carryforward can offset approximately $345 million of taxable pretax income in 2025 and beyond [4][15] Yearly Overview - Total year revenue for 2024 was $599 million, a decrease of $27 million from 2023, with international operations contributing to the decline [16][17] - Income from continuing operations improved to $113.6 million in 2024, compared to $25.5 million in 2023 [16][17] - Adjusted EBITDA for the full year was $99 million, down from $107 million in 2023, with margins decreasing slightly [16][17]
Thiogenesis Announces European Consulting and Investor Relations Agreement
Newsfile· 2025-02-20 14:00
Core Viewpoint - Thiogenesis Therapeutics, Corp. has entered into a consulting and investor relations agreement with Bull Markets Media GmbH to enhance its shareholder base and expand its network in Europe [1][2]. Group 1: Agreement Details - The consulting fee for the agreement is C$60,000, with 50% payable upon signing and the remainder due on June 1, 2025 [3]. - The agreement includes the grant of 100,000 stock options to the consultant, allowing the acquisition of shares at $0.64 each for a term of 3 years, with options vesting in tranches [3]. - The agreement has a duration of twelve months and can be renewed annually for up to two additional years [3]. Group 2: Company Overview - Thiogenesis Therapeutics is a clinical-stage biopharmaceutical company focused on developing sulfur-containing prodrugs aimed at treating serious pediatric diseases with unmet medical needs [5]. - The company utilizes a streamlined 505 (b)(2) regulatory pathway in the US and a hybrid system in Europe for regulatory submissions, which allows for the use of existing safety data [5]. - Initial target indications for the company's products include Mitochondrial Encephalopathy Lactic Acidosis and Stroke (MELAS), Leigh syndrome, Rett syndrome, and pediatric MASH [5]. Group 3: Regulatory and Compliance - The agreement with the consultant is subject to acceptance by the TSX Venture Exchange [4]. - The company has received final acceptance from the TSXV for its investor relations contract with Triomphe Holdings Ltd. [4].